339 related articles for article (PubMed ID: 9246947)
1. Characterization of the AT1 angiotensin II receptor expressed in guinea pig liver.
García-Sáinz JA; Martínez-Alfaro M; Romero-Avila MT; González-Espinosa C
J Endocrinol; 1997 Jul; 154(1):133-8. PubMed ID: 9246947
[TBL] [Abstract][Full Text] [Related]
2. Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
Li Q; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 2001 Apr; 15(2):143-50. PubMed ID: 11468024
[TBL] [Abstract][Full Text] [Related]
3. Characterization of cardiac angiotensin AT1 receptors by [3H]SR 47436.
Delisée C; Schaeffer P; Cazaubon C; Chatelain P
Eur J Pharmacol; 1993 Oct; 247(2):139-44. PubMed ID: 8282003
[TBL] [Abstract][Full Text] [Related]
4. Atypical angiotensin II receptors coupled to phosphoinositide turnover/calcium signalling in catfish hepatocytes.
Olivares-Reyes JA; Macías-Silva M; García-Sáinz JA
Biochim Biophys Acta; 1997 Jun; 1357(2):201-8. PubMed ID: 9223623
[TBL] [Abstract][Full Text] [Related]
5. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS
J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670
[TBL] [Abstract][Full Text] [Related]
6. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
[TBL] [Abstract][Full Text] [Related]
7. Nonpeptide angiotensin II receptor antagonists: in vivo inhibition of [125I-Sar1,Ile8]angiotensin II binding by losartan, EXP597 and L-159,282 in rats.
Wong PC; Herblin WF; Barbera FA; Bernard R; Bozarth TA; Watson CA; Gibson RE
Clin Exp Hypertens; 1996 Feb; 18(2):189-200. PubMed ID: 8869000
[TBL] [Abstract][Full Text] [Related]
8. Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo.
Brown DC; Steward LJ; Ge J; Barnes NM
Br J Pharmacol; 1996 May; 118(2):414-20. PubMed ID: 8735646
[TBL] [Abstract][Full Text] [Related]
9. Binding of valsartan to mammalian angiotensin AT1 receptors.
de Gasparo M; Whitebread S
Regul Pept; 1995 Nov; 59(3):303-11. PubMed ID: 8577935
[TBL] [Abstract][Full Text] [Related]
10. Identification of atypical (non-AT1, non-AT2) angiotensin binding sites with high affinity for angiotensin I on IEC-18 rat intestinal epithelial cells.
Smith RD
FEBS Lett; 1995 Oct; 373(3):199-202. PubMed ID: 7589465
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin AT1 receptors mediate a positive inotropic effect of angiotensin II in guinea pig atria.
Feolde E; Vigne P; Frelin C
Eur J Pharmacol; 1993 Mar; 245(1):63-6. PubMed ID: 8477818
[TBL] [Abstract][Full Text] [Related]
12. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of KR-30988, a novel non-peptide AT1 receptor antagonist, in rat, rabbit and dog.
Lee BH; Lee SH; Jung YS; Seo HW; Yoo SE; Shin HS
J Pharm Pharmacol; 1999 Oct; 51(10):1191-200. PubMed ID: 10579691
[TBL] [Abstract][Full Text] [Related]
14. AT1 receptor characteristics of angiotensin analogue binding in human synovium.
Walsh DA; Suzuki T; Knock GA; Blake DR; Polak JM; Wharton J
Br J Pharmacol; 1994 Jun; 112(2):435-42. PubMed ID: 8075862
[TBL] [Abstract][Full Text] [Related]
15. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
Haddad G; Amiri F; Garcia R
Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
[TBL] [Abstract][Full Text] [Related]
16. Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding.
Fierens FL; Vanderheyden PM; De Backer JP; Vauquelin G
Eur J Pharmacol; 1999 May; 372(2):199-206. PubMed ID: 10395100
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
[TBL] [Abstract][Full Text] [Related]
18. The angiotensin AT(1) receptor antagonist irbesartan has near-peptide affinity and potently blocks receptor signaling.
Hines J; Fluharty SJ; Sakai RR
Eur J Pharmacol; 1999 Nov; 384(1):81-9. PubMed ID: 10611423
[TBL] [Abstract][Full Text] [Related]
19. Rabbit renal epithelial angiotensin II receptors.
Dulin NO; Ernsberger P; Suciu DJ; Douglas JG
Am J Physiol; 1994 Nov; 267(5 Pt 2):F776-82. PubMed ID: 7977780
[TBL] [Abstract][Full Text] [Related]
20. Binding of [3H]angiotensin II and [3H]DuP 753 (Losartan) to rat liver homogenates reveals multiple sites. Relationship to AT1a- and AT1b-type angiotensin receptors and novel nonangiotensin binding sites.
Widdowson PS; Renouard A; Vilaine JP
Peptides; 1993; 14(4):829-37. PubMed ID: 8234032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
